KRYS vs. VERX

In the year-to-date period, KRYS achieves a 19.92% return, which is significantly higher than VERX's -17.13% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and Vertex, Inc. (VERX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current KRYS Sharpe Ratio is 1.17, which is comparable to the VERX Sharpe Ratio of 1.62. The chart below compares the historical Sharpe Ratios of KRYS and VERX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither KRYS nor VERX has paid dividends to shareholders.

The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum VERX drawdown of -75.40%. Use the drawdown chart below to compare losses from any high point for KRYS and VERX. For additional features, visit the drawdowns tool.

Krystal Biotech, Inc. (KRYS) and Vertex, Inc. (VERX) have volatilities of 14.52% and 14.12%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Krystal Biotech, Inc. and Vertex, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.